Abstract CT066: HERTHENA-Lung02: A randomized Phase 3 study of patritumab deruxtecan vs platinum-based chemotherapy in locally advanced or metastatic EGFR-mutated NSCLC after progression with a third-generation EGFR tyrosine kinase inhibitor
Year: 2023
Type: conference-abstract
Source: Cancer Research
Institutions: Montefiore Medical Center, Memorial Sloan Kettering Cancer Center, Guangdong Provincial People's Hospital, The Cancer Institute Hospital, Japanese Foundation For Cancer Research, German Center for Lung Research, LungenClinic Grosshansdorf, Daiichi Sankyo (United States), Chinese University of Hong Kong
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4365512178